MAOB and Parkinson disease: This well-established reputation is closely related to the substrate and tissue specificity of both isoforms: MAO A selective inhibitors are clinically administered as antidepressants [13], while MAO B selective inhibition is typically used for the treatment of the early symptoms of Parkinson’s disease (PD) [14].